Besides, it has been described a reciprocal regulation between ANXA2 and ERG oncoprotein in prostate cancer (Griner et al., 2015) and with HER2 in breast cancer (Shetty et al., 2012). This evidence concerns the gene ANXA2 and breast carcinoma.